Halia Therapeutics: Funding, Investors & Team (Oct 2026)
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments for inflammatory disorders and neurological diseases. The company aims to enhance patient well-being by creating innovative medicines that target the immune system's response to address chronic inflammation and counteract the harm caused by improperly activated immune responses. Halia Therapeutics stands out for its unique approach to drug discovery, utilizing the latest insights on the role of inflammation in various human diseases like cancer and neurodegenerative disorders.
Halia Therapeutics has raised $3.8M across 2 funding rounds on record, the most recent a Convertible Note of $3.5M announced in Aug 2026.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Halia Therapeutics Company Profile and Key Stats
Latest funding round on record: Aug 2026.
Halia Therapeutics Funding Rounds
Halia Therapeutics raised $340k in an undisclosed round announced in Jul 2025.
1.1 years later, a Convertible Note of $3.5M was announced in Aug 2026.
Halia Therapeutics Investors
Halia Therapeutics Founders and Leadership Team
Contact details for the Halia Therapeutics team: 3 of 3 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Halia Therapeutics Funding Compared to Other Biotechnology Startups
Halia Therapeutics' latest round of $3.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Halia Therapeutics in Biotechnology and Lehi
Companies Similar to Halia Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Halia Therapeutics Funding FAQs
What does Halia Therapeutics do?
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments for inflammatory disorders and neurological diseases. The company aims to enhance patient well-being by creating innovative medicines that target the immune system's response to address chronic inflammation and counteract the harm caused by improperly activated immune responses. Halia Therapeutics stands out for its unique approach to drug discovery, utilizing the latest insights on the role of inflammation in various human diseases like cancer and neurodegenerative disorders.
How much funding has Halia Therapeutics raised?
Halia Therapeutics has raised $3.8M across 2 rounds on record. The most recent is a Convertible Note of $3.5M announced in Aug 2026.
When did Halia Therapeutics last raise funding?
Halia Therapeutics' most recent funding round on record is a Convertible Note of $3.5M, announced in Aug 2026.
Who has invested in Halia Therapeutics?
Investors on record for Halia Therapeutics include Todd Pedersen.
Who founded Halia Therapeutics?
FundedIQ lists Jared Bearss (Founder) at Halia Therapeutics.
Where is Halia Therapeutics headquartered?
Halia Therapeutics is based in Lehi, Utah, United States.
How many employees does Halia Therapeutics have?
Halia Therapeutics is in the 11-50 employee band.
When was Halia Therapeutics founded?
Halia Therapeutics was founded in 2017.
How does Halia Therapeutics' funding compare to other Biotechnology startups?
Halia Therapeutics' latest round of $3.5M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Halia Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Halia Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.